Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis (Q33947318)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis |
scientific article |
Statements
1 reference
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis (English)
1 reference
Massimo Loda
1 reference
Giulio Draetta
1 reference
Elisa Benedettini
1 reference
Lynette M Sholl
1 reference
Michael Peyton
1 reference
John Reilly
1 reference
Christopher Ware
1 reference
Lenora Davis
1 reference
Natalie Vena
1 reference
Dyane Bailey
1 reference
Beow Y Yeap
1 reference
Michelangelo Fiorentino
1 reference
Azra H Ligon
1 reference
Bo-Sheng Pan
1 reference
Victoria Richon
1 reference
John D Minna
1 reference
Adi F Gazdar
1 reference
Silvano Bosari
1 reference
Lucian R Chirieac
1 reference
Bart Lutterbach
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference